Kalvista Pharmaceuticals Inc (KALV) Insider Trading
- $45,015,517.47
- $68,838,447.81
- Feb. 20, 2024
- Thomas Andrew Crockett
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Oct. 20, 2020 | Insider | 7,942 | $17.49 | Sell | $138,905.58 | |
Oct. 20, 2020 | CEO | 15,994 | $17.49 | Sell | $279,735.06 | |
Oct. 16, 2020 | CEO | 1,261 | $17.01 | Sell | $21,449.61 | |
Oct. 16, 2020 | Insider | 914 | $17.00 | Sell | $15,538.00 | |
Dec. 16, 2019 | CEO | 5,400 | $17.06 | Sell | $92,124.00 | |
Dec. 16, 2019 | Insider | 3,010 | $17.05 | Sell | $51,320.50 | |
Dec. 13, 2019 | Insider | 1,500 | $17.05 | Sell | $25,575.00 | |
Dec. 12, 2019 | CEO | 100 | $17.00 | Sell | $1,700.00 | |
Sept. 26, 2019 | Director | 2,038 | $11.90 | Buy | $24,252.20 | |
July 29, 2019 | Director | 56,367 | $16.99 | Buy | $957,675.33 | |
July 26, 2019 | Director | 26,500 | $16.83 | Buy | $445,995.00 | |
July 23, 2019 | Insider | 3,300 | $18.62 | Sell | $61,446.00 | |
July 19, 2019 | Director | 61,280 | $17.79 | Buy | $1,090,171.20 | |
July 17, 2019 | Director | 1,280 | $16.96 | Buy | $21,708.80 | |
July 15, 2019 | CEO | 10,000 | $17.04 | Sell | $170,400.00 | |
April 22, 2019 | Insider | 7,355 | $26.04 | Sell | $191,524.20 | |
April 22, 2019 | CFO | 3,073 | $25.70 | Sell | $78,976.10 | |
April 18, 2019 | CFO | 1,073 | $25.51 | Sell | $27,372.23 | |
April 17, 2019 | Insider | 4,000 | $24.92 | Sell | $99,680.00 | |
April 15, 2019 | CEO | 10,000 | $24.80 | Sell | $248,000.00 | |
April 10, 2019 | Major Shareholder | 50,000 | $29.20 | Sell | $1,460,000.00 | |
April 8, 2019 | Major Shareholder | 22,800 | $29.49 | Sell | $672,372.00 | |
April 5, 2019 | Insider | 5,000 | $30.00 | Sell | $150,000.00 | |
April 2, 2019 | Major Shareholder | 97,074 | $28.03 | Sell | $2,720,984.22 | |
March 28, 2019 | Major Shareholder | 124,675 | $28.84 | Sell | $3,595,627.00 | |
March 26, 2019 | Major Shareholder | 30,093 | $29.70 | Sell | $893,762.10 | |
March 18, 2019 | Major Shareholder | 500,000 | $28.75 | Sell | $14,375,000.00 | |
March 14, 2019 | CEO | 3,000 | $30.16 | Sell | $90,480.00 | |
March 4, 2019 | Major Shareholder | 43,378 | $22.91 | Sell | $993,789.98 | |
Feb. 21, 2019 | Major Shareholder | 214,198 | $20.55 | Sell | $4,401,768.90 | |
Jan. 25, 2019 | Insider | 5,453 | $17.06 | Sell | $93,028.18 | |
Jan. 23, 2019 | Insider | 1,902 | $17.01 | Sell | $32,353.02 | |
Jan. 16, 2019 | Insider | 4,000 | $19.55 | Sell | $78,200.00 | |
Jan. 14, 2019 | CEO | 10,000 | $19.33 | Sell | $193,300.00 | |
Jan. 7, 2019 | Major Shareholder | 4,299 | $20.25 | Sell | $87,054.75 | |
Jan. 2, 2019 | Major Shareholder | 200 | $20.00 | Sell | $4,000.00 | |
Dec. 31, 2018 | Major Shareholder | 25,418 | $20.00 | Sell | $508,360.00 | |
Dec. 28, 2018 | Major Shareholder | 3,734 | $20.03 | Sell | $74,792.02 | |
Dec. 19, 2018 | Major Shareholder | 2,136 | $20.02 | Sell | $42,762.72 | |
Sept. 10, 2018 | Director | 1,058,824 | $17.00 | Buy | $18,000,008.00 | |
Oct. 12, 2017 | Major Shareholder | 2,725,283 | $9.64 | Sell | $26,271,728.12 | |
Oct. 12, 2017 | Director | 850,000 | $8.50 | Buy | $7,225,000.00 | |
Sept. 15, 2017 | Major Shareholder | 176,647 | $7.21 | Sell | $1,273,624.87 | |
Sept. 14, 2017 | Major Shareholder | 10,000 | $8.05 | Sell | $80,500.00 | |
Sept. 13, 2017 | Major Shareholder | 25,900 | $8.02 | Sell | $207,718.00 | |
Dec. 30, 2015 | CEO | 10,000 | $3.70 | Sell | $37,000.00 | |
April 14, 2015 | Director | 1,012,500 | $5.00 | Buy | $5,062,500.00 | |
April 14, 2015 | Major Shareholder | 877,500 | $5.00 | Buy | $4,387,500.00 |
Insiders are both buying and selling Kalvista Pharmaceuticals Inc stock.
The insider traders at Kalvista Pharmaceuticals Inc are: Thomas Andrew Crockett, Venrock Healthcare Capital Par, Christopher Yea, Albert Cha, Benjamin L Palleiko, Edward P Feener, Svlsf Iv, Llc, Life Sciences Fund Iv (Gp) Sv, Holdings A/S Novo, Andreas Maetzel, Paul K Audhya, Acmp Iv Llc, David Renzi, Daniel B Soland, Rajeev M Shah, and Michael David Smith
The most active insider trader at Kalvista Pharmaceuticals Inc is Thomas Andrew Crockett with 22 trades.
Holdings A/S Novo has sold the most Kalvista Pharmaceuticals Inc stock with a total value of $54,105,299.11.
Albert Cha has bought the most Kalvista Pharmaceuticals Inc stock with a total value of $29,566,911.61.
The most recent insider trade for Kalvista Pharmaceuticals Inc was on Feb. 20, 2024.
The single biggest insider buy for Kalvista Pharmaceuticals Inc was from Albert Cha with a total value of $18,000,008.00 on Sept. 10, 2018.
The single biggest insider sell for Kalvista Pharmaceuticals Inc was from Holdings A/S Novo with a total value of $26,271,728.12 on Oct. 12, 2017.